183 related articles for article (PubMed ID: 35978340)
1. Identifying patients with malignant spinal cord compression (MSCC) near end of life who can benefit from palliative radiotherapy.
Rades D; Segedin B; Schild SE; Lomidze D; Veninga T; Cacicedo J
Radiat Oncol; 2022 Aug; 17(1):143. PubMed ID: 35978340
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors for local control and survival after radiotherapy of metastatic spinal cord compression.
Rades D; Fehlauer F; Schulte R; Veninga T; Stalpers LJ; Basic H; Bajrovic A; Hoskin PJ; Tribius S; Wildfang I; Rudat V; Engenhart-Cabilic R; Karstens JH; Alberti W; Dunst J; Schild SE
J Clin Oncol; 2006 Jul; 24(21):3388-93. PubMed ID: 16849752
[TBL] [Abstract][Full Text] [Related]
3. Radiotherapy of metastatic spinal cord compression in very elderly patients.
Rades D; Hoskin PJ; Karstens JH; Rudat V; Veninga T; Stalpers LJ; Schild SE; Dunst J
Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):256-63. PubMed ID: 17189074
[TBL] [Abstract][Full Text] [Related]
4. Metastatic spinal cord compression in non-small cell lung cancer patients. Prognostic factors in a series of 356 patients.
Rades D; Douglas S; Veninga T; Bajrovic A; Stalpers LJ; Hoskin PJ; Rudat V; Schild SE
Strahlenther Onkol; 2012 Jun; 188(6):472-6. PubMed ID: 22361746
[TBL] [Abstract][Full Text] [Related]
5. Radiotherapy for oligometastatic disease in patients with spinal cord compression (MSCC) from relatively radioresistant tumors.
Freundt K; Meyners T; Bajrovic A; Basic H; Karstens JH; Adamietz IA; Rudat V; Schild SE; Dunst J; Rades D
Strahlenther Onkol; 2010 Apr; 186(4):218-23. PubMed ID: 20354660
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors in a series of 504 breast cancer patients with metastatic spinal cord compression.
Rades D; Douglas S; Veninga T; Stalpers LJ; Bajrovic A; Rudat V; Schild SE
Strahlenther Onkol; 2012 Apr; 188(4):340-5. PubMed ID: 22354333
[TBL] [Abstract][Full Text] [Related]
7. Functional outcome and survival after radiotherapy of metastatic spinal cord compression in patients with cancer of unknown primary.
Rades D; Fehlauer F; Veninga T; Stalpers LJ; Basic H; Hoskin PJ; Rudat V; Karstens JH; Schild SE; Dunst J
Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):532-7. PubMed ID: 17084539
[TBL] [Abstract][Full Text] [Related]
8. A score predicting posttreatment ambulatory status in patients irradiated for metastatic spinal cord compression.
Rades D; Rudat V; Veninga T; Stalpers LJ; Basic H; Karstens JH; Hoskin PJ; Schild SE
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):905-8. PubMed ID: 18436390
[TBL] [Abstract][Full Text] [Related]
9. Escalation of radiation dose beyond 30 Gy in 10 fractions for metastatic spinal cord compression.
Rades D; Karstens JH; Hoskin PJ; Rudat V; Veninga T; Schild SE; Dunst J
Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):525-31. PubMed ID: 17141977
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors for different outcomes in patients with metastatic spinal cord compression from cancer of unknown primary.
Douglas S; Huttenlocher S; Bajrovic A; Rudat V; Schild SE; Rades D
BMC Cancer; 2012 Jun; 12():261. PubMed ID: 22720880
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors and a survival score for patients with metastatic spinal cord compression from colorectal cancer.
Rades D; Douglas S; Huttenlocher S; Veninga T; Bajrovic A; Rudat V; Schild SE
Strahlenther Onkol; 2012 Dec; 188(12):1114-8. PubMed ID: 23111468
[TBL] [Abstract][Full Text] [Related]
12. A scoring system to predict local progression-free survival in patients irradiated with 20 Gy in 5 fractions for malignant spinal cord compression.
Rades D; Conde-Moreno AJ; Cacicedo J; Veninga T; Segedin B; Stanic K; Schild SE
Radiat Oncol; 2018 Dec; 13(1):257. PubMed ID: 30594231
[TBL] [Abstract][Full Text] [Related]
13. Predictors of Outcomes and a Scoring System for Estimating Survival in Patients Treated With Radiotherapy for Metastatic Spinal Cord Compression From Small-Cell Lung Cancer.
Rades D; Motisi L; Veninga T; Conde-Moreno A; Cacicedo J; Schild SE
Clin Lung Cancer; 2019 Jul; 20(4):322-329. PubMed ID: 31155476
[TBL] [Abstract][Full Text] [Related]
14. Outcomes After Radiotherapy Alone for Metastatic Spinal Cord Compression in Patients with Oligo-metastatic Breast Cancer.
Rades D; Panzner A; Janssen S; Dunst J; Veninga T; Holländer NH; Schild SE
Anticancer Res; 2018 Dec; 38(12):6897-6903. PubMed ID: 30504407
[TBL] [Abstract][Full Text] [Related]
15. Role of the overall treatment time of radiotherapy with 10 × 3 Gy for outcomes in patients with metastatic spinal cord compression.
Rades D; Janssen S; Conde-Moreno AJ; Cacicedo J; Metz M; Veninga T; Segedin B; Rudat V; Schild SE
J Med Imaging Radiat Oncol; 2017 Jun; 61(3):388-393. PubMed ID: 27804231
[TBL] [Abstract][Full Text] [Related]
16. A matched-pair analysis comparing 5x4 Gy and 10x3 Gy for metastatic spinal cord compression (MSCC) in patients with favorable survival prognoses.
Rades D; Huttenlocher S; Veninga T; Bajrovic A; Bremer M; Rudat V; Schild SE
Radiat Oncol; 2015 Apr; 10():90. PubMed ID: 25889036
[TBL] [Abstract][Full Text] [Related]
17. A validated score estimating ambulatory status following radiotherapy of elderly patients for metastatic spinal cord compression.
Rades D; Evers JN; Rudat V; Bajrovic A; Karstens JH; Schild SE
BMC Cancer; 2014 Aug; 14():589. PubMed ID: 25123656
[TBL] [Abstract][Full Text] [Related]
18. Outcome after radiotherapy alone for metastatic spinal cord compression in patients with oligometastases.
Rades D; Veninga T; Stalpers LJ; Basic H; Rudat V; Karstens JH; Dunst J; Schild SE
J Clin Oncol; 2007 Jan; 25(1):50-6. PubMed ID: 17194905
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors predicting functional outcomes, recurrence-free survival, and overall survival after radiotherapy for metastatic spinal cord compression in breast cancer patients.
Rades D; Veninga T; Stalpers LJ; Schulte R; Hoskin PJ; Poortmans P; Schild SE; Rudat V
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):182-8. PubMed ID: 16198069
[TBL] [Abstract][Full Text] [Related]
20. Dose escalation of radiotherapy for metastatic spinal cord compression (MSCC) in patients with relatively favorable survival prognosis.
Rades D; Panzner A; Rudat V; Karstens JH; Schild SE
Strahlenther Onkol; 2011 Nov; 187(11):729-35. PubMed ID: 22037654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
